Thursday, June 27, 2019

Hilleman Labs licenses oral cholera vaccine to Bharat Biotech for development and commercialisation

Hilleman Labs licenses oral cholera vaccine to Bharat Biotech for development and commercialisation Krishna Ella, Chairman Managing Director of Bharat Biotech, said the company has a capacity to deliver 50 million doses per year.

from Moneycontrol Business News https://ift.tt/2LjhVRH

No comments:

Post a Comment

Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL Tech

Indian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Sever...